Rheinmetall Back Above €1,000 as Artillery Order and Rescue-Station Deal Bolster Order Book

Rheinmetall closed at €1,016.00, up 2.5% for the week, as new artillery, frigate and medical orders offset a 35% year-to-date decline.

Rheinmetall shares closed Friday at €1,016.00, lifting the stock back above the psychologically significant €1,000 mark and capping a weekly gain of 2.5%. The recovery follows a sustained stretch of weakness and was set in motion by a cluster of order announcements at the start of the week, giving the MDAX- and DAX-listed defense group fresh operational momentum.

Fresh Orders Land on Both Sides of the Atlantic

On Monday, the company confirmed a new large-scale contract for 155-millimeter artillery ammunition from an international customer. The deal carries a volume in the low triple-digit million-euro range and covers a five-digit number of shells. Production has already begun, with delivery scheduled for completion by the end of 2027, and the order was booked in the third quarter of 2026.

Berlin added further planning certainty the same day, when Defense Minister Pistorius set the course for a fourth fleet replenishment frigate to be built at Rheinmetall's Wolgast yard. Thursday brought news from the UK, where Rheinmetall UK is installing a new vibration test facility at its Telford site to expand local testing capacity.

Investors responded on Tuesday, sending the stock up 3.1% on the day and back through the €1,000 threshold.

Bundeswehr Medical Order Adds to the Backlog

The artillery win follows another substantial award from the German armed forces. On August 17, Rheinmetall reported an order for 149 additional mobile rescue stations worth more than €500 million gross. Combined with a tranche booked in July, the program now totals 165 systems valued at over €600 million.

Those sales successes underpin the expansion course the company laid out in its first-half figures. In its second-quarter 2026 report on August 6, the group disclosed quarterly revenue.

A Record Pipeline, but a Bruising Year

Despite the recent rebound, the year remains difficult for shareholders. The stock is down 35% since the start of 2026. A major drag came more than a month ago, when the Federal Ministry of Defense halted the F126 frigate program, costing Rheinmetall its role as lead contractor and forcing the company to cut its annual revenue forecast by €300 million.

Analysts are split on the outlook. On September 10, JPMorgan placed the stock on its "Negative Catalyst Watch" list while keeping its rating at "Neutral." Goldman Sachs had argued two days earlier that the company retains substantial potential despite the share-price decline, pointing to the large order for mobile rescue stations for the Bundeswehr.

Underpinning the fundamental case is a backlog that recently surpassed €80 billion.

Market participants will get concrete insight into the financial trajectory on November 5, 2026, when Rheinmetall publishes its third-quarter results. A second key date follows on December 9, 2026, when the Bundestag votes on the Arminius project.